The goal of the project is to further the development the Firm's artificial intelligence capabilities and enhance the ability to provide useful analysis from multi-modal data sources in the diagnosis...
EMAGIX INC.
7 enregistrements totalisant 647,026.00 $ CAN, selon les données ouvertes officielles du gouvernement du Canada.
Intégrer ce graphique
Par ministère
| Conseil national de recherches Canada | $647,026 | 7 enregistrements |
Enregistrements
Emagix’s prototype fluorescein angiography software analyses a series of images of the retina to assess the permeability of retinal blood vessels associated with diabetic retinopathy. The objective of...
Diseased blood vessels in the retina are the main cause of vision loss in diseases like age-related macular degeneration and diabetic retinopathy, which collectively affect 380 million individuals wor...
Leaky blood vessels in the retina are the main cause of vision loss in diseases like age-related macular degeneration and diabetic retinopathy – which collectively affect 380 million individuals world...
The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.
The funding provided by the IAP program is intended to assist innovative small and medium-sized enterprises in the start-up phase that cannot access existing commercial support related to COVID-19.
The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.